Abstract:Chronic obstructive pulmonary disease is a severe lung disease characterized by tissue destruction and limited airflow mainly caused by exposure to harmful environmental substances. Primary symptoms of this lung disorder include dyspnea, sputum production, and cough, which leads to respiratory failure. Prevalence increases with age, making it the most common cause of death worldwide. The primary objective of this study was to identify novel therapeutic targets via gene expression meta-analysis and to utilize them for drug reprofiling of FDA-approved drugs in treating chronic obstructive pulmonary disease. Multiple microarray and RNA-seq datasets from alveolar macrophages comprising healthy and diseased patients were processed to pinpoint significant dysregulated genes involved in this disease. Next, a meta-analysis was performed to identify the consistently differentially expressed genes in all datasets. Functional enrichment and protein-protein interaction analyses were conducted to single out the hub genes. Moreover, 3D structure prediction, virtual screening, and molecular dynamics simulations were utilized to explore the selected hub gene for drug repurposing. The number of significantly dysregulated genes identified via RNA-seq and microarray meta-analysis was found to be 104 and 57, respectively. Interestingly, VGLL3, ITIH5, ELOVL7, ACOD1, LAMB1, CXCL9, and GBP5 were common between the two sets revealing their significant association with the disease. CXCL9 and CCL3L3 were identified as the common hub genes between both sets. However, CXCL9, a chemokine, was prioritized for drug repurposing endeavors as it exhibits remarkable involvement in immune response and inflammation. Virtual screening of CXCL9 against selected drugs disclosed that CXCL9 has the highest binding affinity of −7.3 kcal/mol for Nintedanib, and binding affinities ranged from −2.4 kcal/mol to −7.3 kcal/mol. Moreover, Tepotinib and Crizotinib were found to be the second and third top-scoring drugs of −6.8 kcal/mol and −6.2 kcal/mol, respectively. Furthermore, the molecular dynamics simulation revealed that Crizotinib showed the most prominent results; however, its binding affinity is lower than Nintedanib. Therefore, Nintedanib is suggested as the better therapeutic agent to inhibit CXCL9 for treating chronic obstructive pulmonary disease.

Alterations of multiple alveolar macrophage states in chronic obstructive pulmonary disease

Alveolar macrophages in early stage COPD show functional deviations with properties of impaired immune activation

Systemic Alterations in Neutrophils and Their Precursors in Early-Stage Chronic Obstructive Pulmonary Disease

Characterization of the COPD alveolar niche using single-cell RNA sequencing

Alveolar macrophage transcriptomic profiling in COPD shows major lipid metabolism changes

Single-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD

2D cross-omics integrated enrichment analysis reveals insights into COPD pathogenesis

The transcriptional and phenotypic characteristics that define alveolar macrophage subsets in acute hypoxemic respiratory failure

The Aging Microenvironment Shapes Alveolar Macrophage Identity in Aging

Integrated Single Cell Analysis of Human Lung Fibrosis Resolves Cellular Origins of Predictive Protein Signatures in Body Fluids

Multi-modal transcriptomic analysis reveals metabolic dysregulation and immune responses in chronic obstructive pulmonary disease

Transcriptomics Analysis Identifies the Presence of Upregulated Ribosomal Housekeeping Genes in the Alveolar Macrophages of Patients with Smoking-Induced Chronic Obstructive Pulmonary Disease

A Single-Cell Atlas of Small Airway Disease in Chronic Obstructive Pulmonary Disease: A Cross-Sectional Study

Macrophage Dysfunction in Respiratory Disease

Dual polarization of human alveolar macrophages progressively increases with smoking and COPD severity

Alterations in the molecular control of mitochondrial turnover in COPD lung and airway epithelial cells

Activation of CD8+ T Cells in Chronic Obstructive Pulmonary Disease Lung

COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors

Abundance of Non-Polarized Lung Macrophages with Poor Phagocytic Function in Chronic Obstructive Pulmonary Disease (COPD)

NRF2 Activation Reprograms Defects in Oxidative Metabolism to Restore Macrophage Function in Chronic Obstructive Pulmonary Disease

Exploring Inflammatory Dysregulation in Alveolar Macrophages: Implications for Novel Therapeutic Targets in Chronic Obstructive Pulmonary Disease